A phase II trial of pirfenidone (5-methyl-1-phenyl-2-[1H]pyridone), a novel anti-fibrosing agent, in myelofibrosis with myeloid metaplasia

Ruben A. Mesa, Ayalew Tefferi, Michelle A. Elliott, H. Clark Hoagland, Timothy G. Call, Georgene S. Schroeder, Soo Young Yoon, Chin Yang Li, Leigh A. Gray, S. Margolin, C. Christopher Hook

Research output: Contribution to journal › Article › peer-review

41 Scopus citations

Fingerprint

Dive into the research topics of 'A phase II trial of pirfenidone (5-methyl-1-phenyl-2-[1H]pyridone), a novel anti-fibrosing agent, in myelofibrosis with myeloid metaplasia'. Together they form a unique fingerprint.

Medicine & Life Sciences